Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc. scores highest on Anchor (57) and lowest on Price (1). Its PosiPenta is 28.07 out of 100, weaker than most similar companies.
On the Penta Grid this week, Syndax Pharmaceuticals, Inc. is Grid #785 of 836 in the Healthcare sector in United States, and Grid #3,713 of 3,999 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Syndax Pharmaceuticals, Inc. | 28.07 | 1 | 46 | 31 | 6 | 57 |
| Kardigan, Inc. | 46.53 | 29 | 35 | 38 | 68 | 63 |
| Omeros Corporation | 61.85 | 38 | 54 | 80 | 97 | 41 |
| GoodRx Holdings, Inc. | 61.84 | 38 | 86 | 84 | 49 | 51 |
| Tandem Diabetes Care, Inc. | 38.60 | 7 | 68 | 52 | 27 | 39 |
| OPKO Health, Inc. | 55.41 | 40 | 38 | 86 | 54 | 59 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -5.12 |
| P/B ratio | 76.29 |
EEarnings
| Trailing EPS | ₹-238.68 |
| Forward EPS | ₹-79.48 |
NNitro
| Price | 1221.82 |
| 52-week high | 2423.76 |
| 52-week low | 1213.77 |
| Fall from 52-week high | 49.6% |
TTorque
| Return on equity (ROE) | -255.93% |
| Debt-to-equity | 39.03 |
AAnchor
| Beta (price swings) | 0.42 |
| Market cap | ₹10,910 Cr |
| Insider holding | 1.69% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Syndax Pharmaceuticals, Inc.'s PosiPenta score?
Syndax Pharmaceuticals, Inc.'s PosiPenta is 28.07 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Syndax Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, Syndax Pharmaceuticals, Inc. is Grid #785 of 836 in the Healthcare sector in United States, and Grid #3,713 of 3,999 in United States.
Which PosiPenta pillar is strongest for Syndax Pharmaceuticals, Inc.?
Anchor (stability and dividends), with a score of 57 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Syndax Pharmaceuticals, Inc.?
Price (valuation), with a score of 1 out of 100: much weaker than most similar companies.
Has Syndax Pharmaceuticals, Inc.'s PosiPenta changed since last week?
Yes, it rose 1.90 points, from 26.17 to 28.07.
PositoAI is for research and education only and is not investment advice.